We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessment of histopathological alterations in patients with chronic hepatitis B infection following long-term oral antiviral therapy.
- Authors
Şahin, Ahmet; Namıduru, Mustafa; Balkan, Ayhan; Karaoğlan, İlkay; Gülşen, Murat T.
- Abstract
Objectives: To evaluate the histopathological changes in the liver after oral antiviral therapy in patients with chronic hepatitis B. Methods: A total of 79 HBeAg-negative and positive patients who had been on lamivudine, entecavir, or tenofovir disoproxil for at least 3 years prior to inclusion were enrolled between March 2015 and 2016, retrospectively. There were 23 patients on lamivudine, 21 patients on entecavir, and 35 on tenofovir. All patients underwent a follow-up liver biopsy. Biochemical, serological, virological and histopathological data were recorded in all patients and were compared after at least 3 years of treatment with oral antiviral agents. Results: Histological activity index scores were reduced in patients who received lamivudine (p=0.011), entecavir (p=0.002), and tenofovir (p=0.001). Also, in contrast with a significant improvement in fibrosis scores in lamivudine (p=0.033) and tenofovir (p=0.001) groups no improvements were found in patients who received entecavir (p=0.090). Conclusion: Long term treatment with oral antiviral agents was associated with biochemical, virological, serological, and histopathological improvements. Long-term use of anti-viral agents as well as continuous suppression of HBV DNA are prerequisites for histopathological improvement.
- Subjects
CHRONIC hepatitis B; ANTIVIRAL agents; LAMIVUDINE; TENOFOVIR; HISTOPATHOLOGY
- Publication
Saudi Medical Journal, 2018, Vol 39, Issue 10, p999
- ISSN
0379-5284
- Publication type
Article
- DOI
10.15537/smj.2018.10.23056